AUTOLOGOUS BONE MARROW TRANSPLANTATION USING C-MYB (LR-3001) [G-4460] ANTISENSE OLIGODEOXYNUCLEOTIDE TREATED BONE MARROW IN CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC OR ACCELERATED PHASE.

Trial Profile

AUTOLOGOUS BONE MARROW TRANSPLANTATION USING C-MYB (LR-3001) [G-4460] ANTISENSE OLIGODEOXYNUCLEOTIDE TREATED BONE MARROW IN CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC OR ACCELERATED PHASE.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Jan 2015

At a glance

  • Drugs G 4460 (Primary) ; Busulfan; Cyclophosphamide
  • Indications Chronic myeloid leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top